Table 5 Surgeons’ knowledge about the staging of PC
Staging of Pancreatic Cancer | Agree (%) | Disagree (%) | Unsure (%) | Missing (%) | |
|---|---|---|---|---|---|
T-staging | TX: Unable to judge | 553(78.4) | 95(13.5) | 7(1.0) | 50(7.1) |
T0: No evidence of primary tumor | 496(70.4) | 168(23.8) | 11(1.6) | 30(4.3) | |
T1: Tumor limited to the pancreas, ≤2 cm in longest dimension | 567(80.4) | 102(14.5) | 9(1.3) | 27(3.8) | |
T2: Tumor limited to the pancreas, >2 cm in longest dimension | 478(67.8) | 163(23.1) | 15(2.1) | 49(7.0) | |
T3: Extension beyond the pancreas, no involvement of the celiac or the superior mesenteric artery | 534(75.7) | 109(15.5) | 27(3.8) | 35(5.0) | |
T4: Tumor involves the celiac or superior mesenteric artery | 556(78.9) | 106(15.0) | 17(2.4) | 26(3.7) | |
N-staging | NX: Unable to judge | 540(76.6) | 97(13.8) | 7(1.0) | 61(8.7) |
N0: No regional lymph node metastasis | 612(86.8) | 76(10.8) | 5(0.7) | 12(1.7) | |
N1: Regional lymph node metastasis | 623(88.4) | 50(7.1) | 5(0.7) | 27(3.8) | |
M-staging | MX: Unable to judge | 638(90.5) | 22(3.1) | 29(4.1) | 16(2.3) |
M0: No distant metastasis | 569(80.7) | 45(6.4) | 47(6.7) | 44(6.2) | |
M1: Distant metastasis | 622(88.2) | 58(8.2) | 1(0.1) | 24(3.4) | |